Fidelity Investments
TNYA icon

Fidelity Investments’s Tenaya Therapeutics TNYA Stock Holding History

Fidelity Investments’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71K Hold
2,308
– – ﹤0.01% 5180
2026
Q1 		$1.6K Sell
2,308
-456
-16% -$337 ﹤0.01% 5068
2025
Q4 		$1.97K Hold
2,764
– – ﹤0.01% 5015
2025
Q3 		$4.48K Hold
2,764
– – ﹤0.01% 4808
2025
Q2 		$1.69K Sell
2,764
-23,456
-89% -$11.9K ﹤0.01% 4878
2025
Q1 		$14.9K Sell
26,220
-8,453
-24% -$8.34K ﹤0.01% 4344
2024
Q4 		$49.6K Sell
34,673
-1,311,265
-97% -$2.94M ﹤0.01% 3854
2024
Q3 		$2.6M Buy
1,345,938
+25,503
+2% +$72K ﹤0.01% 2323
2024
Q2 		$4.09M Sell
1,320,435
-1,589,691
-55% -$6.56M ﹤0.01% 2139
2024
Q1 		$15.2M Buy
2,910,126
+255,375
+10% +$1.22M ﹤0.01% 1750
2023
Q4 		$8.6M Sell
2,654,751
-532,000
-17% -$1.15M ﹤0.01% 1895
2023
Q3 		$8.13M Sell
3,186,751
-567,488
-15% -$2.38M ﹤0.01% 1891
2023
Q2 		$22M Sell
3,754,239
-6,057
-0.2% -$35.2K ﹤0.01% 1602
2023
Q1 		$10.7M Buy
3,760,296
+929,820
+33% +$2.61M ﹤0.01% 1848
2022
Q4 		$5.69M Sell
2,830,476
-294,822
-9% -$720K ﹤0.01% 2079
2022
Q3 		$9.06M Sell
3,125,298
-2,403,744
-43% -$11.2M ﹤0.01% 1934
2022
Q2 		$31.1M Sell
5,529,042
-662,966
-11% -$5.36M ﹤0.01% 1470
2022
Q1 		$72.9M Buy
6,192,008
+468,276
+8% +$5.67M 0.01% 1222
2021
Q4 		$107M Buy
5,723,732
+620,255
+12% +$13.5M 0.01% 1076
2021
Q3 		$102M Buy
+5,103,477
New +$110M 0.01% 1100

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments's TNYA Position: Q2 2026 in Review

Fidelity Investments held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 2,308 shares worth $1.71K. The position accounts for ﹤0.01% of the portfolio, ranked #5180.

Fidelity Investments first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $107M in Q4 2021. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Fidelity Investments held 2,308 shares of Tenaya Therapeutics worth $1.71K as of Q2 2026.
  • Fidelity Investments left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5180 holding.
  • Fidelity Investments first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Tenaya Therapeutics position peaked at $107M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.